Quarterly Report

Vaxcyte, Inc. Filed 2024-05-08 Acc 0001628280-24-021677

Documents 1

2024-08-06 10-Q Quarterly Report
2024-05-08 10-Q Quarterly Report
2024-05-08 8-K Results of operations
2024-05-03 4 SVP, GEN COUNSEL & CORP SEC sold 1,667 shares at an average $61.74 ($102,921)
2024-05-03 4 CHIEF OPERATING OFFICER sold 3,000 shares at an average $61.65 ($184,942)
2024-05-03 4 CHIEF EXECUTIVE OFFICER sold 2,616 shares at an average $61.70 ($161,419)
2023-11-06 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading pcvx-20240331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…